ArticleCancers2024

Outcome of Atezolizumab Plus Bevacizumab Combination Therapy in High-Risk Patients with Advanced Hepatocellular Carcinoma.

Sang Youn Hwang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.